Search results
Results from the WOW.Com Content Network
Shares of catalyst-rich pharma Merck & Co., Inc. (NYSE: MRK) are poised for further upside, according to an analyst at SVB Leerink.The Merck Analyst: Daina Graybosch maintained an Outperform ...
In January 2015, Merck acquired Cubist Pharmaceuticals for $102 per share in cash or about $9.5 billion in total. [94] In July 2015, Merck and Ablynx expanded their 18-month-old immuno-oncology collaboration by four years, generating a potential $4.4 billion in milestone payments for the Abylnx. [95]
Merck is forecasting 2024 revenue to climb by 5% to 7% over the 2023 result, while its earnings-per-share (EPS) target of $7.94 to $8.04 represent a midpoint increase of 7% from the company record ...
Merck's new forecast includes a $0.26 per share charge for its $680 million acquisition of cancer drug developer Harpoon Therapeutics, which closed in the first quarter of 2024, the company said.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
With the lower re-negotiated a lower price of $21.5 billion between Johnson & Johnson and Guidant, Boston Scientific announced an unsolicited offer of $24.6 billion for Guidant (an offer of $72 per share of Guidant, $36 in cash and a fixed number of Boston Scientific shares valued at $36 a share). 26 2006 Johnson & Johnson: Guidant: 24.2 37
The S&P 500 is a stock market index maintained by S&P Dow Jones Indices.It comprises 503 common stocks which are issued by 500 large-cap companies traded on the American stock exchanges (including the 30 companies that compose the Dow Jones Industrial Average).
The decision comes a little over a week after President Donald J. Trump singled out rival Pfizer over its price increases. The list price of Zepatier had been $54,600 for a course of treatment ...